Literature DB >> 36056239

Analysis of clinicopathological features and NAB2-STAT6 fusion variants of meningeal solitary fibrous tumor with ectopic salivary gland components in the cerebellopontine angle.

Takahiro Shirakura1, Yuichi Yamada2, Satoshi Nakata3, Bunsho Asayama4, Yoshinobu Seo4, Satoshi Tanikawa5,6, Takayuki Kato7, Nobukazu Komoribayashi8,9, Naohiko Kubo9, Nobuhiro Monma10, Naoki Okura11, Shinya Tanaka5,6, Yoshinao Oda2, Junko Hirato1,12, Hideaki Yokoo1, Sumihito Nobusawa13.   

Abstract

Solitary fibrous tumors (SFTs) are rare mesenchymal tumors that can occur at any location. Since the identification of specific NAB2-STAT6 fusion in SFTs, the fusion gene variants, NAB2 exon 4-STAT6 exon 2/3 and NAB2 exon 5/6/7-STAT6 exon 16/17/18, have been reported to be associated with clinicopathological features, and the latter variant is predominant in meningeal SFTs. SFTs developing in the salivary glands are rare, and more rarely, those involving ectopic salivary glands (ESGs) have been reported in the cerebellopontine angle (CPA); however, their characteristics remain not well understood. In this study, we performed a clinicopathological and molecular analysis of 3 cases of meningeal SFT with ESGs. All cases presented with an extra-axial mass in the CPA, which is a rarer location for intracranial ESGs compared to the sellar region. Histologically, except for the presence of ESGs, there was no significant difference between current cases and ordinary SFTs. The ESGs demonstrated no cellular atypia, and although the spindle tumor cells were immunopositive for STAT6, the ESGs were negative in all cases, supporting that the ESGs are non-neoplastic components. In 1 case, ESGs were found only in the primary tumor and disappeared in recurrence/dissemination. Of note, molecular analysis identified NAB2 exon 4-STAT6 exon 2 in all cases. In conclusion, our results suggest that ESGs particularly in the CPA may be associated with SFTs and that meningeal SFTs with ESGs may be associated with the minor fusion variant of NAB2-STAT6 in the intracranial lesions.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Ectopic salivary gland; Hemangiopericytoma; NAB2; STAT6; Solitary fibrous tumor

Year:  2022        PMID: 36056239     DOI: 10.1007/s00428-022-03403-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  46 in total

1.  Clinicopathological differences between variants of the NAB2-STAT6 fusion gene in solitary fibrous tumors of the meninges and extra-central nervous system.

Authors:  Satoko Nakada; Hiroshi Minato; Takayuki Nojima
Journal:  Brain Tumor Pathol       Date:  2016-06-06       Impact factor: 3.298

2.  Prognostic significance of NAB2-STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear.

Authors:  Rob Vogels; Nicolas Macagno; Klaus Griewank; Patricia Groenen; Marian Verdijk; Judy Fonville; Benno Kusters; Dominique Figarella-Branger; Pieter Wesseling; Corinne Bouvier; Uta Flucke
Journal:  Acta Neuropathol       Date:  2019-02-02       Impact factor: 17.088

3.  Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential.

Authors:  Keisuke Akaike; Aiko Kurisaki-Arakawa; Kieko Hara; Yoshiyuki Suehara; Tatsuya Takagi; Keiko Mitani; Kazuo Kaneko; Takashi Yao; Tsuyoshi Saito
Journal:  Hum Pathol       Date:  2014-12-10       Impact factor: 3.466

4.  TERT promoter mutations in solitary fibrous tumour.

Authors:  Elizabeth G Demicco; Khalida Wani; Davis Ingram; Michael Wagner; Robert G Maki; Anthony Rizzo; Alan Meeker; Alexander J Lazar; Wei-Lien Wang
Journal:  Histopathology       Date:  2018-09-19       Impact factor: 5.087

5.  NAB2-STAT6 fusion types account for clinicopathological variations in solitary fibrous tumors.

Authors:  Hui-Chun Tai; I-Chieh Chuang; Tse-Ching Chen; Chien-Feng Li; Shih-Chiang Huang; Yu-Chien Kao; Po-Chun Lin; Jen-Wei Tsai; Jui Lan; Shih-Chen Yu; Shao-Lun Yen; Shih-Ming Jung; Kuan-Cho Liao; Fu-Min Fang; Hsuan-Ying Huang
Journal:  Mod Pathol       Date:  2015-07-31       Impact factor: 7.842

6.  Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features.

Authors:  Sarah Barthelmeß; Helene Geddert; Carsten Boltze; Evgeny A Moskalev; Matthias Bieg; Horia Sirbu; Benedikt Brors; Stefan Wiemann; Arndt Hartmann; Abbas Agaimy; Florian Haller
Journal:  Am J Pathol       Date:  2014-02-08       Impact factor: 4.307

7.  NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor.

Authors:  Karen J Fritchie; Long Jin; Brian P Rubin; Peter C Burger; Sarah M Jenkins; Sarah Barthelmeß; Evgeny A Moskalev; Florian Haller; Andre M Oliveira; Caterina Giannini
Journal:  J Neuropathol Exp Neurol       Date:  2016-02-16       Impact factor: 3.685

8.  Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.

Authors:  Laura Schirosi; Sylvie Lantuejoul; Alberto Cavazza; Bruno Murer; Pierre Yves Brichon; Mario Migaldi; Giuliana Sartori; Alessandro Sgambato; Giulio Rossi
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

9.  Solitary fibrous tumor: a case series identifying pathological adverse factors-implications for risk stratification and classification.

Authors:  Isidro Machado; Gema Nieto Morales; Julia Cruz; Javier Lavernia; Francisco Giner; Samuel Navarro; Antonio Ferrandez; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2019-09-16       Impact factor: 4.064

10.  Molecular changes in solitary fibrous tumor progression.

Authors:  Hyung Kyu Park; Dan Bi Yu; Minjung Sung; Ensel Oh; Mingi Kim; Ji-Young Song; Mi-Sook Lee; Kyungsoo Jung; Ka-Won Noh; Sungbin An; Kyoung Song; Do-Hyun Nam; Yu Jin Kim; Yoon-La Choi
Journal:  J Mol Med (Berl)       Date:  2019-07-18       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.